Angus Liu

Hackers recently accessed Amgen’s cloud environment, stealing sensitive patient health information and proprietary company data, the company disclosed in a securities filing on Friday.

In a milestone for IgA nephropathy, Otsuka’s Voyxact has shown for the first time in a phase 3 trial that a drug can stabilize patients’ kidney function decline to the normal rate seen in healthy a

After a yearslong struggle, Jazz Pharmaceuticals has called time on Zepzelca as a second-line treatment for small cell lung cancer.

Johnson & Johnson has named Tom Cavanaugh as the next leader of its innovative medicines business, beginning Sept. 1, 2026.

Long viewed as one of the biggest hype-to-disappointment stories in pharmaceutical history, the PCSK9 cholesterol drug class has struggled to live up to its commercial promise. Merck & Co.

AstraZeneca and Bristol Myers Squibb do not have any ongoing discussions about a potential deal,

Gilead Sciences' HIV prevention business reached a milestone, exceeding $1 billion in quarterly sales for the first time.

AstraZeneca and CSPC Pharmaceutical are strengthening their partnership by establishing a new biologics manufacturing joint venture in China.

Two and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”

In his first earnings call just days after becoming Sarepta Therapeutics